Molecular diagnostics offer a path toward more personalized bladder cancer care. To make this paper as useful as possible, I can:
Use of diagnostic algorithms for classifying urothelial carcinomas.
Identification of nucleic acid and protein expression profiles (mRNA signatures).
Here is a proposed structure and summary for a paper based on this content.
on the "209 gen alg" mentioned in the Professional Rates_APR2022 dataset. Professional Rates_APR2022
Epidemiology of bladder cancer in the U.S. (incidence and mortality). Limitations of current diagnosis (cystoscopy, cytology). The need for molecular biomarkers.
